Biohit Oyj - Annual report/ annual accounts

Publication of Biohit Oyj Annual Report 2013

Biohit Oyj Stock Exchange Release March 24, 2014 at 2:45 pm local time (EET)


Biohit Oyj's Annual Report 2013 is published today as PDF document. The annual
report contains a review of information published in 2013. 

Report is available in English and Finnish at Biohit company website
www.biohithealthcare.com/investors. Printed publication of Annual Report 2013
will be distributed to shareholders in Annual General Meeting. 


Attachment: Biohit Oyj Annual Report 2013


Additional information:

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's
mission is “Innovating for Health” - we produce innovative products and
services to promote research and early diagnosis. Biohit is headquartered in
Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B
share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com

Attachments:

Biohit_VSK_2013_EN_net.pdf